BR112015013182A2 - composição compreendendo uma triazina para uso na proteção de um animal não humano contra uma doença infecciosa - Google Patents

composição compreendendo uma triazina para uso na proteção de um animal não humano contra uma doença infecciosa

Info

Publication number
BR112015013182A2
BR112015013182A2 BR112015013182A BR112015013182A BR112015013182A2 BR 112015013182 A2 BR112015013182 A2 BR 112015013182A2 BR 112015013182 A BR112015013182 A BR 112015013182A BR 112015013182 A BR112015013182 A BR 112015013182A BR 112015013182 A2 BR112015013182 A2 BR 112015013182A2
Authority
BR
Brazil
Prior art keywords
triazine
protection
infectious disease
human animal
composition
Prior art date
Application number
BR112015013182A
Other languages
English (en)
Inventor
Karembe Hamadi
Cilliers Hannelie
Guyonnet Jérôme
Krejci Roman
Original Assignee
Ceva Sante Animale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47351540&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112015013182(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ceva Sante Animale filed Critical Ceva Sante Animale
Priority to BR122021005310-3A priority Critical patent/BR122021005310B1/pt
Priority to BR122021005311-1A priority patent/BR122021005311B1/pt
Publication of BR112015013182A2 publication Critical patent/BR112015013182A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Dispersion Chemistry (AREA)

Abstract

resumo composição compreendendo uma triazina para uso na proteção de um animal não humano contra uma doença infecciosa a invenção também se refere a métodos melhorados para proteger animais não humanos com compostos de triazina por injeção(ões) intramuscular(es) ou subcutânea(s). a invenção pode ser usada com várias triazinas, como toltrazuril, em diferentes animais não humanos, como um suíno, um ovino, um bovino, um canino, um felino ou uma ave, para protegê-los contra doenças infecciosas, como distúrbios causados por protozoários.
BR112015013182A 2012-12-07 2013-12-06 composição compreendendo uma triazina para uso na proteção de um animal não humano contra uma doença infecciosa BR112015013182A2 (pt)

Priority Applications (2)

Application Number Priority Date Filing Date Title
BR122021005310-3A BR122021005310B1 (pt) 2012-12-07 2013-12-06 Composição compreendendo uma triazina
BR122021005311-1A BR122021005311B1 (pt) 2012-12-07 2013-12-06 Composição compreendendo uma triazina

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12306546.8A EP2740469A1 (en) 2012-12-07 2012-12-07 New treatments with triazines
PCT/EP2013/075755 WO2014086958A1 (en) 2012-12-07 2013-12-06 New treatments with triazines

Publications (1)

Publication Number Publication Date
BR112015013182A2 true BR112015013182A2 (pt) 2017-07-11

Family

ID=47351540

Family Applications (3)

Application Number Title Priority Date Filing Date
BR112015013182A BR112015013182A2 (pt) 2012-12-07 2013-12-06 composição compreendendo uma triazina para uso na proteção de um animal não humano contra uma doença infecciosa
BR122021005310-3A BR122021005310B1 (pt) 2012-12-07 2013-12-06 Composição compreendendo uma triazina
BR122021005311-1A BR122021005311B1 (pt) 2012-12-07 2013-12-06 Composição compreendendo uma triazina

Family Applications After (2)

Application Number Title Priority Date Filing Date
BR122021005310-3A BR122021005310B1 (pt) 2012-12-07 2013-12-06 Composição compreendendo uma triazina
BR122021005311-1A BR122021005311B1 (pt) 2012-12-07 2013-12-06 Composição compreendendo uma triazina

Country Status (23)

Country Link
US (1) US9877969B2 (pt)
EP (3) EP2740469A1 (pt)
JP (1) JP6125034B2 (pt)
KR (1) KR102253497B1 (pt)
CN (3) CN104981233A (pt)
AU (1) AU2013353982B2 (pt)
BR (3) BR112015013182A2 (pt)
CA (1) CA2892886C (pt)
CL (1) CL2015001563A1 (pt)
CY (1) CY1123190T1 (pt)
DK (1) DK2928454T3 (pt)
ES (1) ES2778950T3 (pt)
FR (1) FR20C1044I2 (pt)
HR (1) HRP20200630T1 (pt)
HU (2) HUE049950T2 (pt)
MX (1) MX2015007128A (pt)
NL (1) NL301064I2 (pt)
PH (1) PH12015501220A1 (pt)
PL (1) PL2928454T3 (pt)
PT (1) PT2928454T (pt)
RU (1) RU2696265C2 (pt)
SI (1) SI2928454T1 (pt)
WO (1) WO2014086958A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007025908A1 (de) 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulierungen enthaltend Triazinone und Eisen
EP2740470A1 (en) * 2012-12-07 2014-06-11 Ceva Sante Animale Treatment of Coccidiosis with intramuscular triazine composition
EP2740469A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale New treatments with triazines
EP2740492A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale Triazine formulations with a second active ingredient and surfactant(s)
EP3578182A1 (en) 2018-06-05 2019-12-11 Bayer Animal Health GmbH Formulations containing triazinones and iron with a low amount of free iron ions
EP3578181A1 (en) 2018-06-05 2019-12-11 Bayer Animal Health GmbH Formulation for use in the simultaneous treatment of coccidial infections and iron deficiencies

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1183940A (en) 1966-10-22 1970-03-11 Fisons Pharmaceuticals Ltd Ferric Hydroxide Complexes
DE2718799A1 (de) 1977-04-27 1978-11-09 Bayer Ag 1-(4-phenoxy-phenyl)-1,3,5-triazin- derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel und wachstumsfoerderer
US4493826A (en) * 1982-01-25 1985-01-15 Schering Corporation Gentamicin-gleptoferron compositions
US5219853A (en) 1983-01-12 1993-06-15 Bayer Aktiengesellschaft Agent for coccidiosis
DE3300793A1 (de) 1983-01-12 1984-07-12 Bayer Ag, 5090 Leverkusen Coccidiosemittel
DE3516632A1 (de) 1985-05-09 1986-11-13 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 1,3,5-triazintrionen
JPH0776524A (ja) * 1993-07-13 1995-03-20 Takeda Chem Ind Ltd 動物用抗貧血剤
DE19603984A1 (de) 1996-02-05 1997-08-07 Bayer Ag Granulate von Triazinen
DE19603954C2 (de) 1996-02-05 2003-04-17 Wagon Automotive Gmbh Prallträger für ein Kraftfahrzeug
DE19824483A1 (de) 1998-06-02 1999-12-09 Bayer Ag Halbfeste wäßrige Zubereitungen für orale Applikation von Toltrazuril-Sulfon
EP1119255A4 (en) 1998-10-08 2009-04-15 New Ace Res Company NEW COMPOSITIONS AND METHOD FOR THE PREVENTION AND TREATMENT OF PROTOCOL DISEASES
WO2001026660A1 (en) 1999-10-08 2001-04-19 New Ace Research Company Novel compositions and methods for prevention and treatment of protozoal disease
DE10040174A1 (de) * 2000-08-17 2002-02-28 Bayer Ag Verwendung von Triazintrion-Sulfonen zur Bekämpfung von Coccidiosen
EP2532378B1 (en) 2004-12-01 2016-04-27 AcuShot, Inc. Needle-free injector
BRPI0712427B8 (pt) 2006-06-07 2021-06-22 Acushot Inc mecanismo de carregamento para um injetor sem agulha
DE102006038292A1 (de) 2006-08-16 2008-02-21 Bayer Healthcare Ag Transdermale Anwendung von Triazinen zur Bekämpfung von Coccidien-Infektionen
DE102007025908A1 (de) * 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulierungen enthaltend Triazinone und Eisen
TW201006515A (en) 2008-03-07 2010-02-16 Pharmajet Inc Intradermal injector and uses thereof
SI22751A (sl) 2008-04-03 2009-10-31 Krka, D.D., Novo Mesto Toltrazuril z izboljĺ animi lastnostmi za raztapljanje
FR2946882B1 (fr) 2009-06-18 2011-08-26 Ceva Sante Animale Suspension veterinaire gelifiee de fer
CN101947201B (zh) 2010-09-08 2011-12-28 洛阳惠中兽药有限公司 兽药纳米混悬剂及其制备方法与应用
CN102512366A (zh) 2011-12-28 2012-06-27 广州市和生堂动物药业有限公司 妥曲珠利悬浮乳剂及其制备方法
CN102743334A (zh) 2012-07-30 2012-10-24 郑州后羿制药有限公司 一种妥曲珠利注射剂及其制备方法
EP2740469A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale New treatments with triazines
EP2740492A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale Triazine formulations with a second active ingredient and surfactant(s)
EP2740470A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale Treatment of Coccidiosis with intramuscular triazine composition
EP3578181A1 (en) 2018-06-05 2019-12-11 Bayer Animal Health GmbH Formulation for use in the simultaneous treatment of coccidial infections and iron deficiencies

Also Published As

Publication number Publication date
CN112370454A (zh) 2021-02-19
CN104981233A (zh) 2015-10-14
CA2892886C (en) 2021-09-07
AU2013353982B2 (en) 2018-01-04
EP2928454A1 (en) 2015-10-14
CY1123190T1 (el) 2021-10-29
JP6125034B2 (ja) 2017-05-10
SI2928454T1 (sl) 2020-07-31
JP2016501252A (ja) 2016-01-18
FR20C1044I2 (fr) 2021-10-15
KR20150104565A (ko) 2015-09-15
BR122021005310B1 (pt) 2022-01-25
AU2013353982A1 (en) 2015-06-11
ES2778950T3 (es) 2020-08-12
CN113144202A (zh) 2021-07-23
DK2928454T3 (da) 2020-03-30
FR20C1044I1 (pt) 2020-10-30
PH12015501220B1 (en) 2015-08-17
RU2696265C2 (ru) 2019-08-01
MX2015007128A (es) 2015-10-14
PT2928454T (pt) 2020-04-23
CA2892886A1 (en) 2014-06-12
BR122021005311B1 (pt) 2022-01-25
HRP20200630T1 (hr) 2020-07-10
PL2928454T3 (pl) 2020-08-24
KR102253497B1 (ko) 2021-05-21
RU2015127025A (ru) 2017-01-12
US20150313905A1 (en) 2015-11-05
EP3721869A1 (en) 2020-10-14
CL2015001563A1 (es) 2015-10-23
EP2740469A1 (en) 2014-06-11
EP2928454B1 (en) 2020-03-18
WO2014086958A1 (en) 2014-06-12
PH12015501220A1 (en) 2015-08-17
HUS2000037I1 (hu) 2020-10-28
US9877969B2 (en) 2018-01-30
NL301064I2 (nl) 2021-03-03
HUE049950T2 (hu) 2020-11-30

Similar Documents

Publication Publication Date Title
BR112015013182A2 (pt) composição compreendendo uma triazina para uso na proteção de um animal não humano contra uma doença infecciosa
BRPI0911031B8 (pt) compostos de piperidina ligada do tipo quinoxalina substituídos e os usos destes
CL2018001744A1 (es) Compuestos depsipeptídicos como anthelmínticos
CO2017011738A2 (es) Compuestos depsipeptídicos como anthelmínticos
UY32923A (es) Compuestos policíclicos como antagonistas del receptor de ácido lisofosfatídico
BR112016003201A2 (pt) inibidores de grp94 seletivos e usos dos mesmos
BRPI0923855A8 (pt) Ácido lipóico, e, composição de ração de animal de estimação
MX2017005721A (es) Composicion veterinaria masticable agradable al paladar.
UY32926A (es) Compuestos como antagonistas de los receptores de ácido lisofosfatídico
BR112012023046A2 (pt) vacinas de vírus de febre aftosa recombinantes e seus respectivos usos
BR112015032341A2 (pt) conservação de composições para cuidados pessoais
BR112012015960A2 (pt) Composições incluindo piruvato para animais de companhia e métodos de uso destas.
BR112018075162A2 (pt) composições para higiene bucal
MX2013002949A (es) Composiciones de acido abscisico para salud animal.
BR112013010136A2 (pt) vacina, composição terapêutica e métodos para o tratamento ou inibição de gliblastoma
NZ707174A (en) Compositions and methods of use of an inappetance-controlling compound
AR097143A1 (es) Composición alimenticia mineral para lamer para rumiantes y método para prepararla
NZ622869A (en) Stable veterinary anthelmintic formulations
MX2016007309A (es) Proceso para preparar una composicion anti-helmintica, composicion anti-helmintica, metodo de tratamiento veterinario y metodo de tratamiento anti-helmintico.
BR112013019675B8 (pt) Composições imunogênicas de bordetella bronchiseptica
EA201401202A1 (ru) ВАКЦИНАЦИЯ РЕСПИРАТОРНЫМ КОРОНАВИРУСОМ СОБАК ДЛЯ ЗАЩИТЫ ОТ ИНФЕКЦИЙ B.Bronchiseptica
BR112015002727A2 (pt) combinação, uso de uma combinação, composição farmacêutica, uso de uma composição farmacêutica, kit, e, método para tratamento de uma infecção ou doença relacionada a tal infecção em humanos ou animais.
BR112015002984A2 (pt) composição, vacina para proteger um animal contra uma infecção com bactérias leptospira, e, uso de ácido cítrico.
BR112016007057A2 (pt) um método veterinário para induzir êmese
CL2016000586A1 (es) Composición que comprende fósforo para uso en prevenir deformidades en peces triploides

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL